Glioblastoma, also known as glioblastoma
multiforme (GBM), is one of the most aggressive and deadly forms of brain
cancer. It originates in the glial cells of the brain and rapidly invades
surrounding brain tissue, making it extremely challenging to treat. Despite its
severity, ongoing research and advanced treatment options offer hope for better
management and improved quality of life.
What Is
Glioblastoma?
Glioblastoma is a type of primary brain tumor that
arises from astrocytes — the supportive cells in the brain. It is classified as
a Grade IV astrocytoma by the World Health Organization (WHO),
indicating a high-grade and fast-growing malignancy.
This cancer most commonly affects adults between the ages of
45 and 70, although it can occur at any age. It accounts for about 15%
of all brain tumors and is more prevalent in men than in women.
Symptoms
of Glioblastoma
Symptoms of glioblastoma depend on the tumor’s location in
the brain. Common signs include:
- Persistent headaches,
especially worse in the morning
- Seizures
- Nausea
and vomiting
- Cognitive
decline or memory problems
- Changes
in personality or behavior
- Speech
difficulties
- Weakness
or numbness in parts of the body
- Vision
problems
These symptoms may develop gradually or suddenly, depending
on the tumor’s growth rate and location.
Causes
and Risk Factors
The exact cause of glioblastoma is not known, but several
risk factors may increase its likelihood:
- Genetic
mutations in tumor suppressor genes or oncogenes
- Radiation
exposure to the head (especially high doses)
- Family
history of brain cancer (rare)
- Age
and gender: More common in older males
- Certain inherited
syndromes, such as Li-Fraumeni or Turcot syndrome
How Is
Glioblastoma Diagnosed?
Early diagnosis is crucial for managing glioblastoma. The
diagnostic process often includes:
- Neurological
examination
- MRI
or CT scan of the brain
- Biopsy or
surgical removal of tumor tissue for histopathology
- Molecular
and genetic testing (e.g., MGMT promoter methylation, IDH
mutation status) to guide personalized treatment
Treatment
Options
While glioblastoma is difficult to cure, a multimodal
treatment approach can extend survival and improve symptoms.
1. Surgery
The first step is often maximal safe resection,
aiming to remove as much of the tumor as possible without harming brain
function.
2. Radiation Therapy
Radiotherapy is typically administered after surgery to
destroy remaining cancer cells and slow tumor growth.
3. Chemotherapy
The most common chemotherapy drug used is Temozolomide
(TMZ), often combined with radiation.
4. Targeted Therapy
Drugs like bevacizumab (Avastin) may be
used to inhibit the growth of blood vessels feeding the tumor.
5. Tumor Treating Fields (TTF)
A newer, FDA-approved therapy that uses electric fields to
disrupt cancer cell division.
6. Clinical Trials and Immunotherapy
Ongoing trials are exploring CAR T-cell therapy,
vaccines, and personalized immunotherapies for glioblastoma.
Prognosis
Glioblastoma is an aggressive cancer with a median
survival of 12 to 15 months with treatment. However, survival can vary
widely depending on factors like age, overall health, and tumor genetics. Some
patients, particularly those with favorable biomarkers (e.g., IDH mutation),
may live longer.
Living
with Glioblastoma
A glioblastoma diagnosis is life-altering. Patients and
families often benefit from:
- Multidisciplinary
care including neurosurgeons, oncologists, and palliative care
specialists
- Support
groups and counseling
- Rehabilitation
therapy for speech, movement, or cognition
- Nutritional
and lifestyle support
Final
Thoughts
Glioblastoma is a complex and challenging disease, but
advances in medical science are paving the way for better treatments and longer
survival. If you or a loved one is facing glioblastoma, seeking care from a
specialized neuro-oncology center can make a significant difference.
Disclaimer: This blog is for informational purposes
only and is not a substitute for professional medical advice.
